1. Introduction

Climate disclosure by biotechnology manufacturing firms refers to the legal and regulatory obligation, or in some jurisdictions a voluntary commitment, to disclose information about how a company's operations affect the climate and how climate change may affect its business.

Biotechnology manufacturers include companies producing:

Vaccines, biologics, and pharmaceutical products.

Gene therapies, cell therapies, and diagnostic products.

Industrial enzymes, fermentation-based chemicals, and biofuels.

Laboratory reagents and biological materials.

Agricultural biotechnology products and genetically engineered biological inputs.

These businesses may have substantial energy demands, temperature-controlled storage, specialized cleanrooms, fermentation systems, water-intensive processes, and complex global supply chains. Their climate disclosures can therefore involve both environmental impacts and operational risks.

The central legal question is:

When must a biotechnology manufacturer disclose its greenhouse-gas emissions, climate-related financial risks, environmental liabilities, and climate transition plans—and what legal consequences follow if its disclosures are misleading, incomplete, or omitted?

There is no single worldwide statute governing every aspect of this subject. The applicable rules depend on the jurisdiction, the company's listing status, its size, its activities, and the reporting period.

2. Legal framework governing climate disclosure

A. India

For Indian biotechnology manufacturers, the principal framework is the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, together with the Business Responsibility and Sustainability Report (BRSR) requirements and applicable environmental laws.

The key provisions are:

Regulation 34(2)(f), SEBI LODR Regulations: provides the basis for BRSR reporting by covered listed entities.

BRSR environmental indicators: address energy consumption, greenhouse-gas emissions, water use, waste management, and environmental performance.

BRSR Core: establishes a specified set of ESG metrics for applicable listed entities, with an assurance/assessment framework that has evolved through SEBI's amendments.

Value-chain disclosures: may require information concerning relevant upstream and downstream partners, subject to the applicable thresholds and current SEBI requirements.

SEBI introduced BRSR in 2021 and made it mandatory for the top 1,000 listed entities by market capitalization from financial year 2022–23.

Securities and Exchange Board of India+2

Application to biotechnology: A listed vaccine manufacturer may need to report electricity consumption in cold-storage facilities, emissions from manufacturing plants, water consumption, and waste generated by biological production. A private biotech company that is not itself subject to BRSR may still face climate-data requests from listed customers, lenders, or investors.

B. European Union

The EU's Corporate Sustainability Reporting Directive (CSRD) and European Sustainability Reporting Standards (ESRS) establish a framework for sustainability reporting by companies falling within their scope.

Climate disclosures under ESRS E1 can address:

Climate-change mitigation and adaptation.

Greenhouse-gas emissions and relevant emissions scopes.

Transition plans and decarbonization targets.

Climate-related risks, opportunities, and financial effects.

Energy consumption and the company's strategy for reducing emissions.

The framework uses double materiality: companies assess both how sustainability matters affect the business financially and how the business affects people and the environment.

A biotech manufacturer with EU operations, or one belonging to a group covered by the applicable rules, must determine its reporting obligations based on the relevant scope, thresholds, exemptions, and phase-in rules. Not every biotech supplier is automatically required to publish a standalone CSRD report.

C. United States

US climate-disclosure obligations require particular care because the regulatory position has changed.

The SEC adopted climate-related disclosure amendments in March 2024, but stayed them on April 4, 2024, amid litigation. In May 2026, the SEC proposed rescinding those amendments. The proposed rescission should not be confused with a final repeal.

SEC+2

Accordingly, a biotechnology company should not assume that the 2024 SEC climate rule is currently an operative reporting requirement. It must separately consider other applicable securities-law disclosure duties, state laws, contractual requirements, and foreign reporting obligations.

D. International reporting standards

The following frameworks can help biotech manufacturers develop consistent climate data:

ISSB IFRS S2: climate-related financial disclosures.

GHG Protocol: accounting for Scope 1, Scope 2, and Scope 3 emissions.

GRI Standards: reporting on organizational impacts, including environmental impacts.

TCFD recommendations: a widely used foundation for climate governance, strategy, risk management, and metrics.

These frameworks do not automatically create statutory duties in every country. Their legal effect depends on whether a regulator, applicable law, stock exchange, contract, or reporting policy incorporates them.

3. What climate information should biotech manufacturers disclose?

CGMP CRISPR Facility - IPS

1. Greenhouse-gas emissions

Quantify direct emissions from boilers, generators, refrigerant leakage, and other controlled sources (Scope 1); purchased electricity and energy (Scope 2); and relevant supply-chain emissions (Scope 3), where applicable or material.

2. Energy-intensive production

Explain the energy requirements of cleanrooms, sterilization, fermentation, purification, refrigeration, and temperature-controlled storage, including efficiency measures and renewable-energy use.

PUURS PFIZER COVID-19 VACCIN PRODUCTION

3. Physical climate risks

Identify flood, heatwave, drought, storm, and power-disruption risks to manufacturing plants, laboratories, cold chains, and essential biological inputs.

Pharmaindustrie Wasseraufbereitung ⇒ Lösungen entdecken! | EnviroChemie

4. Water, waste, and environmental controls

Disclose relevant water consumption, wastewater treatment, hazardous and biological waste handling, and environmental incidents. Explain their climate relevance without treating every environmental metric as a greenhouse-gas metric.

RheinEnergie and Infineum are planning a large solar installation in Cologne

5. Targets and transition plans

State emissions-reduction targets, baseline years, deadlines, capital expenditure, renewable-energy plans, and progress achieved. Disclose important assumptions and avoid unsupported claims of carbon neutrality.

The applicable reporting framework determines which metrics are mandatory. The list above is a practical compliance framework, not a claim that every company must publish every item under every jurisdiction.

4. Important case laws and their legal significance

A critical distinction is necessary: many leading judgments concern securities disclosure, environmental responsibility, or climate governance generally. They are relevant to biotechnology manufacturers by analogy, but they are not necessarily judgments about climate-disclosure violations by biotech companies specifically.

Case 1: TSC Industries, Inc. v. Northway, Inc. (1976)

United States Supreme Court · 426 U.S. 438 (1976)

Facts and issue: The dispute concerned alleged omissions in corporate proxy materials. The Court considered the standard for deciding whether an omitted fact is material.

Judgment: The Court held that information is material where there is a substantial likelihood that a reasonable shareholder would consider it important, such that it would significantly alter the total mix of information available.

Justia U.S. Supreme Court Center+1

Application to biotech climate disclosure:

Suppose a listed biologics manufacturer knows that its principal manufacturing facility faces a significant flood risk, threatening production and causing potential losses. If the risk could materially affect the company's financial position or business strategy, omitting it from a relevant securities disclosure may raise materiality questions.

The company does not necessarily need to disclose every minor environmental event. The issue is whether the information is material under the applicable legal standard and reporting rules.

Legal principle: Materiality depends on the importance of the omitted information to the relevant investor decision.

Case 2: Basic Inc. v. Levinson (1988)

United States Supreme Court · 485 U.S. 224 (1988)

Facts and issue: Basic made public statements denying merger discussions while negotiations were occurring. The dispute concerned materiality and securities-fraud liability.

Judgment: The Court rejected a rigid bright-line approach to materiality and adopted a fact-specific assessment. It also addressed reliance on public statements in securities markets.

Justia U.S. Supreme Court Center+1

Application to biotech manufacturers:

A biotechnology company may publicly announce a net-zero manufacturing target while internally abandoning the investments required to achieve it. If the public statement is materially misleading under the applicable law, the inconsistency could expose the company to securities litigation or regulatory scrutiny.

Not every missed target establishes fraud. Relevant questions include the statement's wording, the information available when it was made, the company's knowledge, materiality, applicable disclosure duties, and the required elements of the particular claim.

Legal principle: Corporate statements and omissions must be evaluated in context; a misleading sustainability claim can become a securities-law issue when the relevant legal requirements are satisfied.

Case 3: Milieudefensie et al. v. Royal Dutch Shell plc (2021)

District Court of The Hague · ECLI:NL:RBDHA:2021:5339

Facts and issue: Environmental organizations and others sought an order requiring Shell to reduce its carbon emissions.

Judgment: In 2021, the Dutch court ordered Shell to reduce its aggregate global CO₂ emissions by a net 45% by the end of 2030, measured against 2019 levels. The judgment addressed corporate responsibility for climate change, rather than merely the publication of climate data.

Application to biotech manufacturers:

The case illustrates that climate-related corporate responsibilities can extend beyond the accuracy of annual reports. For a manufacturer with energy-intensive facilities and a substantial emissions footprint, climate strategy, mitigation measures, and supply-chain impacts can raise legal and governance questions.

Important qualification: The Hague Court of Appeal subsequently overturned the specific reduction order in November 2024. It recognized that companies may have climate-related obligations but did not impose the same company-wide reduction order. The 2021 target should therefore not be presented as an unchanged, currently binding order.

clientearth.org

Legal principle: Climate litigation may challenge corporate conduct and transition strategies independently of whether a disclosure document is technically complete.

Case 4: ClientEarth v. Shell plc — derivative proceedings against directors (2023)

High Court of Justice, England and Wales · [2023] EWHC 1897 (Ch)

Facts and issue: ClientEarth sought permission to pursue a derivative claim against Shell's directors, alleging failures in managing climate-related risks and compliance with directors' duties.

Judgment: The High Court refused permission to continue the claim. The proceedings raised questions about directors' duties, the board's discretion over climate strategy, and the demanding requirements for derivative litigation.

Application to biotech manufacturers:

Directors of a biotech company should oversee significant climate risks where these affect the company's long-term interests, business continuity, or legal obligations. Board oversight should include reliable emissions data, realistic targets, risk assessment, and appropriate controls over public claims.

However, directors are not automatically liable merely because a climate target is disputed or a transition strategy is unsuccessful.

Legal principle: Climate governance can become a corporate-governance issue, but liability depends on the applicable duties, evidence, procedural rules, and facts.

clientearth.org

Case 5: Vellore Citizens' Welfare Forum v. Union of India (1996)

Supreme Court of India · (1996) 5 SCC 647

Facts and issue: The case concerned environmental damage caused by tanneries, including pollution affecting water and agricultural resources.

Judgment: The Supreme Court recognized the precautionary principle and the polluter-pays principle as essential features of Indian environmental law.

Application to biotech manufacturers:

A biological manufacturing facility that pollutes waterways, mishandles waste, or causes environmental harm may face regulatory action, remediation obligations, or other liability under applicable law.

Climate disclosure is not the same as environmental pollution liability. Nevertheless, the case supports a broader compliance approach in which manufacturers identify environmental risks, prevent harm, and maintain reliable records of their environmental performance.

Legal principle: Environmental protection may require preventive measures and allocation of the costs of pollution to responsible parties. The case does not itself establish a general mandatory climate-reporting duty.

Case 6: M.C. Mehta v. Union of India — Oleum Gas Leak case (1987)

Supreme Court of India · (1987) 1 SCC 395

Facts and issue: The litigation followed a leak of oleum gas from an industrial establishment in Delhi and raised questions about liability for hazardous industrial activities.

Judgment: The Supreme Court developed the doctrine of absolute liability for enterprises engaged in hazardous or inherently dangerous activities, subject to the doctrine's legal scope.

Application to biotech manufacturers:

A facility handling hazardous chemicals, biological agents, or other dangerous materials should distinguish climate-related risks from industrial-safety risks. A climate report does not replace compliance with environmental, factory-safety, waste-management, or other applicable regulations.

If climate hazards exacerbate an industrial incident, the facts may raise multiple issues: emergency preparedness, operational negligence, environmental damage, and the accuracy of prior risk statements.

Legal principle: Environmental and industrial hazards can generate independent legal duties. This judgment is not a direct climate-disclosure precedent.

5. How the cases fit together

The first two cases are securities-disclosure authorities from the United States. The next two concern climate governance in Europe. The final two are Indian environmental-law authorities. They provide complementary principles, but they do not create one uniform, global duty to disclose climate information.

6. Legal consequences of inaccurate or incomplete climate disclosures

A biotechnology manufacturer may face different consequences depending on the nature of the disclosure failure and the jurisdiction.

A. Regulatory enforcement

In India, failure to comply with applicable SEBI reporting requirements may lead to regulatory directions, penalties, or other enforcement measures under the securities-law framework. Environmental violations may separately attract action under the applicable environmental statutes.

B. Securities litigation

Investors may allege that material misstatements or omissions concerning climate risks distorted investment decisions or security prices. The outcome depends on the governing law, available evidence, causation, loss, and the elements of the claim.

C. Greenwashing claims

Unsupported assertions such as “100% carbon-neutral manufacturing” or “zero-emission production” may invite scrutiny where they are false, misleading, or insufficiently substantiated under applicable consumer-protection, advertising, securities, or other laws.

D. Contractual and financing consequences

Inaccurate emissions data may breach supplier agreements, sustainability-linked financing terms, customer codes of conduct, or representations made during due diligence. Consequences depend on the relevant contract.

These consequences are not automatic. A reporting error, a reasonable estimate later revised, a misleading statement, and deliberate fraud are legally distinct situations.

7. Corporate liability and accountability

Climate disclosure requires coordination between the board, management, technical teams, and external assurance providers.

Delegating data collection to a sustainability team does not necessarily eliminate the board's or management's responsibilities under applicable law.

8. Practical compliance checklist for biotechnology manufacturers

The following checklist is a useful starting point for an annual climate-disclosure programme.

Annual reporting readiness

0 of 10

Identify the jurisdictions, listing rules, and reporting standards applicable to the company.

Map manufacturing sites, laboratories, warehouses, and critical suppliers.

Prepare a documented greenhouse-gas inventory and record calculation methods.

Assess flood, heat, drought, power-supply, and cold-chain risks.

Evaluate the material financial effects of climate risks and transition plans.

Set measurable emissions targets with baselines, deadlines, and supporting budgets.

Substantiate carbon-neutrality, renewable-energy, and other environmental claims.

Reconcile climate metrics with financial statements and other public disclosures.

Maintain evidence, source records, approvals, and internal controls.

Obtain any assurance or assessment required by the applicable reporting framework.

Copy checklist

9. Illustrative legal problem

Facts: An Indian listed biotechnology company reports that its manufacturing emissions have fallen by 30%. However, the reported figure excludes emissions from a major facility, and the company has no documented basis for its carbon-neutrality claim.

Legal analysis:

Reporting compliance: Determine which BRSR indicators and reporting requirements apply to the company and whether the omitted facility should have been included.

Materiality: Assess whether the omission makes the reported emissions figure materially inaccurate or misleading.

Evidence: Examine utility bills, fuel records, emissions calculations, facility boundaries, assumptions, and management approvals.

Public statements: Evaluate whether the carbon-neutrality claim is adequately substantiated and compliant with applicable law.

Remedial action: Correct the underlying data, assess whether a formal correction or regulatory notification is required, and strengthen internal controls.

Liability: Determine whether the facts support regulatory action, contractual remedies, investor claims, or other legal proceedings.

The principles in TSC Industries and Basic v. Levinson may help explain materiality in a US securities-law context. In India, the applicable SEBI requirements and Indian law would govern the actual reporting obligation and available remedies.

10. Conclusion

Climate disclosure by biotechnology manufacturing firms sits at the intersection of securities regulation, corporate governance, environmental law, and financial risk management.

The most important legal principles are:

Material climate information must be disclosed when applicable law requires it.

Sustainability claims must be assessed for accuracy and substantiation.

Environmental compliance and climate reporting are related but distinct obligations.

Directors and senior management should establish reliable controls for climate-related information.

Judicial decisions on securities materiality and environmental responsibility can guide analysis, but their legal effect depends on jurisdiction and context.

For an Indian biotechnology manufacturer, the most practical starting point is to map its SEBI BRSR obligations, applicable environmental permits, emissions data, and the accuracy of its public climate claims.

A useful next step: I can develop this into an India-focused legal research note covering the exact SEBI provisions, statutory penalties, and additional Indian judgments relevant to climate and ESG disclosure.